On The Horizon

 In this episode of the WTR Small Cap Spotlight, WTR Managing Director for Natural Resources Jeff Robertson joins host Tim Gerdeman to preview second quarter 2026 earnings season for the U.S. energy sector. Recorded July 27, 2026 — as the majority of companies in WTR's universe are set to report — the conversation covers how producers are managing renewed oil price volatility driven by military strikes in the Persian Gulf, the key themes emerging from early reports by Halliburton, SLB, Range Resources, and EQT, and what investors should expect from WTR's coverage universe across oilfield services (FET, D-NOW, Select Water Solutions, Nessah), U.S. producers (High Peak, Ring, Prairie, Riley, W&T Offshore, Evolution Petroleum), and Africa-focused operators Maren Energy and Valco Energy. Robertson also addresses M&A activity, free cash flow priorities, and the development drilling catalysts that could drive volume growth into 2027. 

Ron Yekutiel, Co-Founder, Chairman, President, and CEO of Kaltura, Inc. (NASDAQ: KLTR), joins the latest WTR Small-Cap Spotlight for an in-depth look at the company’s next chapter. In conversation with host Tim Gerdeman and WTR analyst James Kisner, Yekutiel explains how Kaltura is moving from a long-standing leadership position in enterprise video to an AI-powered, agentic digital experience platform. He outlines how the company is combining its core technology with photorealistic conversational avatars from the eSelf acquisition and intent-based journey orchestration from PathFactory to transform customer, employee, learner, and audience experiences.

During the episode, Yekutiel demonstrates his own digital twin, an avatar that presents Kaltura’s investor deck, answers questions, and switches to Japanese on command. The discussion also covers the two agentic solutions planned for release in the second half of 2026, the strategic importance of Kaltura’s real-time experience layer, and how the leadership team is balancing investment in growth with adjusted EBITDA profitability and positive cash flow.

Dr. Elazar Sonnenschein, Founder and CEO of Pulsenmore Ltd. (Nasdaq and Tel Aviv: PLSM), joins host Tim Gerdeman and WTR equity research analyst James Kisner on this episode of On the Horizon. Pulsenmore has built the first FDA De Novo–authorized, prescription home-use prenatal ultrasound, allowing expectant mothers to capture images on a handheld device for remote physician review.

Sonnenschein walks through the company’s journey from concept to creating an entirely new regulatory category, what it takes to deliver a home scan clinicians can trust, and how years of real-world use shaped the platform. The conversation explores Pulsenmore’s U.S. commercial launch, its proving ground in Israel, and a broader women’s health strategy that now extends into fertility and IVF monitoring. He also shares his perspective on scaling the business and what investors should be watching over the year ahead.

Sam Teo, Acting CEO of Treasure Global, Inc. (NASDAQ: TGL), joins the WTR On The Horizon podcast to walk through the company's ZCITY Super App and the strategy behind it. Host Joe Brunetto, Director of WTR Horizons and Business Analyst at Water Tower Research, guides the conversation from the founding vision through the platform's dual-sided consumer-and-merchant model, its "coopetition" positioning alongside players like Grab and Shopee, and the AI-driven "data flywheel" at the center of the business.

Sam and Joe dig into the catalysts management is watching—ARPU stepping up from $213 to $1,506 in a single quarter, rising engagement, and AI and enterprise initiatives including the V Gallant cloud-infrastructure agreement, the Silica-AI partnership, and the ELMU Smart Campus contract. They also cover recent financial momentum against an ongoing investment phase, Malaysia's home-market runway, and the planned rollout across Indonesia, Vietnam, Thailand, the Philippines, and Japan, closing with the proof points investors should watch over the next few quarters.  

Listen on Apple Podcasts, Spotify, or at www.watertowerresearch.com.

In this episode of the On The Horizons podcast, Mike Logozzo, CEO, and Tom Kutzman, CFO of reAlpha Tech Corp. (NASDAQ: AIRE), join host Tim Gerdeman, Vice Chair, Co-Founder, and Chief Marketing Officer of Water Tower Research, and WTR Analyst James Kisner.

reAlpha is developing an AI-powered homebuying platform designed to coordinate real estate brokerage, mortgage, and title services on a single platform. The platform is anchored by Claire, the company's proprietary AI homebuying concierge, and a rebate-at-closing model that rewards buyers who utilize multiple reAlpha services.

Mike Logozzo walks through the "One reAlpha" vision, the progress of the Prevu integration, and the strategic rationale behind the proposed InstaMortgage acquisition, which would bring direct mortgage lending onto the platform. Tom Kutzman outlines a return-driven spending initiative encompassing headcount realignment, AI productivity gains, and vendor optimization.

The conversation closes with reAlpha's priorities for the remainder of 2026, including completing the InstaMortgage transaction, converting platform visitors into customers during the spring and summer buying season, and expanding services into additional states.

In this episode of On The Horizon, Dr. Siyu Huang, Founder and CEO of Factorial Energy, joins host Tim Gerdeman and WTR analyst Eric Goldstein to discuss why solid-state batteries are finally crossing from lab to road. The conversation covers Factorial's two platforms — FEST® for drones and defense, Solstice for robotics and energy storage — joint development agreements with strategic partners including Mercedes-Benz, Stellantis, Hyundai, and Kia, a strategic investment from IQT, the venture arm of the U.S. national security community, and why defense and drone markets may generate revenue well ahead of the automotive ramp. Dr. Huang also explains the company's capital-light business model and how it plans to scale without building its own gigafactories.

In this episode, Christer Rosen, Founder and CEO of Jupiter Neurosciences (Nasdaq: JUNS), and President & COO Alison Silva join Water Tower Research’s Tim Gerdeman and Healthcare Analyst Robert Sassoon to discuss Jotrol, the company’s proprietary micellar formulation of resveratrol engineered to overcome long‑standing bioavailability and tolerability limitations. Jotrol has demonstrated a ninefold increase in resveratrol bioavailability, enabling therapeutic exposure without the high‑dose GI side effects that have historically constrained the molecule’s therapeutic potential.

The team highlights progress on the active Phase 2A Parkinson’s trial enrolling at Georgetown University, designed to evaluate safety, PK, and neuroinflammatory biomarkers, with data expected in early 2027. Management also outlines Jupiter’s dual‑engine strategy spanning clinical development, a consumer longevity brand, and new licensing initiatives including ALA‑002.

In this episode of the On The Horizon podcast, Tal Jacobson, CEO of Perion Network (NASDAQ: PERI), joins host Tim Gerdeman and WTR's James Kisner to discuss how the repositioned, AI-native Perion is tackling fragmentation in the trillion-dollar digital ad market. Jacobson walks through Perion One — a platform that sits above ad-buying platforms like Google, YouTube, Meta, and TikTok, rather than replacing them — and Outmax, the company's AI agent that applies algorithmic-trading methodology to media buying for 52 Fortune 100 companies. Because Perion owns no inventory, it can recommend shifting spend to whichever channel delivers the best outcome — an edge single-channel players can't match. The conversation covers Q4 momentum, growth in CTV, Digital Out-of-Home, and Retail Media, partnerships with Amazon, Walmart Connect, and Mastercard, and a three-year plan targeting 20%+ organic ex-TAC CAGR, 28% EBITDA margins by 2028, and $300M+ in cash.

On this episode of On the Horizon, Gary Atkinson, CEO of Algorhythm Holdings (NASDAQ: RIME), joins host Tim Gerdeman and WTR’s James Kisner. The discussion centers on SemiCab, the company’s AI-driven collaborative optimization platform built to reduce empty truck miles and improve freight network efficiency by turning one-off shipments into continuous, multi-stop flows. Atkinson highlights accelerating managed-services traction with major consumer brands in India, the real-world operating benefits the platform has delivered for customers, and the longer-term opportunity to expand into the U.S. through the higher-margin APEX SaaS offering. The conversation also covers growth milestones for 2026, the advantages of the company’s asset-light model, and how management is thinking about scaling the business while funding continued expansion.

In this episode of I, Oren Hershkovitz, CEO of Enlivex, joins host Tim Gerdeman, Vice Chair, Co-Founder, and CMO of Water Tower Research, along with Dr. John Roy, WTR’s Senior Equity Research Analyst. The conversation explores the evolved corporate strategy of Enlivex, a clinical-stage immunotherapy company that has pioneered a dual-pillar approach combining traditional drug development with a high-exposure digital asset treasury (DAT). Unlike companies that focus their treasuries on Bitcoin, Enlivex is the first public company to center its strategy around prediction markets, specifically the RAIN decentralized protocol. This novel approach allows the company to potentially leverage yield enhancement activities from its digital assets to aggressively fund the clinical development of its lead immunotherapy candidate, Allocetra, currently in late-stage trials for age-related osteoarthritis.